Braskem A ADR earnings beat by $0.09, revenue topped estimates
Braskem A ADR (BAK) reported Q3 EPS of $0.083, beating estimates by $0.09, with revenue at $3.81B, exceeding expectations. The stock is down 43.78% over 3 months and 62.95% over 12 months. InvestingPro rates its financial health as 'fair performance'.
How this was made
The 30-second read
Why it matters
The earnings beat provides fresh data for traders to reassess valuation.
Market read
Earnings surprise may prompt short-term buying interest.
What to watch
Potential headwinds from commodity price volatility and currency fluctuations could offset the earnings beat.
Background
Braskem A ADR is a Brazilian petrochemical company listed on NYSE as an ADR.
Ticker impact
Braskem A ADR reported Q3 EPS of $0.083, beating estimates by $0.09 and revenue of $3.81B versus $3.55B consensus.
potential modest upside as market prices in the earnings beat
The beat on both earnings and revenue provides fresh positive data, but the company is already down sharply over the past year, limiting upside.
Market effects
Chemicals sector may see slight lift from a major player beating expectations.
Brazilian and Latin American markets could react modestly.
Limited global impact; primarily relevant to investors in Braskem and related chemicals stocks.
Counterpoint
Given the steep decline over the past year, the beat may be already priced in, limiting upside.
Key entities
- companyBraskem A ADR
Brazilian petrochemical producer listed as ADR on NYSE.



